EUVIMEDSkopri EUVIMED
LeserbriefKommentar

Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply

Yao Tong, De-Hua Chang iD, Yu-Dong Xiao iD

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17423 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, 2023. Written by Yao Tong and 2 co-authors. Institution: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Radiofrequency Ablation, Catheter Ablation. Cited 1 times so far (Crossref); 8 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Tong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17263 and https://doi.org/10.1111/apt.17409

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRadiofrequency AblationCatheter AblationHumansHepatectomyTreatment OutcomeNeoplasm Recurrence, LocalRetrospective Studies

Authors and institutions

  • Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.

ORCID profiles: De-Hua Chang, Yu-Dong Xiao

Cite

APA

Tong, Y., Chang, D. H., & Xiao, Y. D. (2023). Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17423

Vancouver

Tong Y, Chang DH, Xiao YD. Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17423

BibTeX
@article{Tong2023,
  author = {Tong, Yao and Chang, De-Hua and Xiao, Yu-Dong},
  title = {Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates – authors' reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17423}
}
Start for free →